(Q36178499)

12 August 2017

Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies (English)

1 reference

Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.

12 August 2017

0 references

Orthoebolavirus zairense

0 references

corrigendum / erratum

0 references

John H Beigel

6

0 references

author name string

Surender Khurana

1

1 reference

12 August 2017

Sandra Fuentes

2

1 reference

12 August 2017

Elizabeth M Coyle

3

1 reference

12 August 2017

Supriya Ravichandran

4

1 reference

12 August 2017

Richard T Davey

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

31 October 2016

1 reference

12 August 2017

1 reference

12 August 2017

22

1 reference

12 August 2017

1439-1447

1 reference

12 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.4201

12 August 2017

0 references

cites work

Ebola vaccine--an urgent international priority

1 reference

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

21 January 2018

1 reference

Interim results from a phase 3 Ebola vaccine study in Guinea

21 January 2018

1 reference

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain

21 January 2018

1 reference

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

21 January 2018

1 reference

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

21 January 2018

1 reference

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

21 January 2018

1 reference

Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses

21 January 2018

1 reference

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

21 January 2018

1 reference

Epitopes involved in antibody-mediated protection from Ebola virus

21 January 2018

1 reference

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

21 January 2018

1 reference

Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine

21 January 2018

1 reference

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

21 January 2018

1 reference

Unique human immune signature of Ebola virus disease in Guinea

21 January 2018

1 reference

CLINICAL TRIALS. Ebola vaccines face daunting path to approval

21 January 2018

1 reference

Approaches to demonstration of Ebola virus vaccine efficacy

21 January 2018

1 reference

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus

21 January 2018

1 reference

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

21 January 2018

1 reference

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines

21 January 2018

1 reference

Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection

21 January 2018

1 reference

Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies

21 January 2018

1 reference

Structures of protective antibodies reveal sites of vulnerability on Ebola virus

21 January 2018

1 reference

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

21 January 2018

1 reference

The I-TASSER Suite: protein structure and function prediction.

21 January 2018

1 reference

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

21 January 2018

1 reference

ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

21 January 2018

1 reference

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

21 January 2018

1 reference

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins

21 January 2018

1 reference

HUMORAL IMMUNITY. T cell help controls the speed of the cell cycle in germinal center B cells.

21 January 2018

1 reference

Class-switched memory B cells remodel BCRs within secondary germinal centers

21 January 2018

1 reference

DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults

21 January 2018

1 reference

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect

21 January 2018

1 reference

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine

21 January 2018

1 reference

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

21 January 2018

1 reference

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27798615

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27798615

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.4201

1 reference

12 August 2017

1 reference